Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma (Q38471731)

3 September 2017

title

Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma (English)

1 reference

3 September 2017

1 reference

Eero Pukkala

1 reference

3 September 2017

Timo Joensuu

1 reference

3 September 2017

Bengt Glimelius

1 reference

3 September 2017

Lois B Travis

1 reference

3 September 2017

Deirdre Hill

1 reference

3 September 2017

Marilyn Stovall

1 reference

3 September 2017

Flora E van Leeuwen

1 reference

3 September 2017

Susan A Smith

1 reference

3 September 2017

Graça M Dores

1 reference

3 September 2017

Mary Gospodarowicz

1 reference

3 September 2017

Eric Holowaty

1 reference

3 September 2017

Michael Andersson

1 reference

3 September 2017

Charles F Lynch

1 reference

3 September 2017

David Pee

1 reference

3 September 2017

Mars B Van't Veer

1 reference

3 September 2017

Hans Storm

1 reference

3 September 2017

John D Boice

1 reference

3 September 2017

Ethel Gilbert

1 reference

3 September 2017

Mitchell H Gail

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

Journal of the National Cancer Institute

3 September 2017

published in

1 reference

3 September 2017

1 reference

3 September 2017

1 reference

3 September 2017

page(s)

1428-1437

1 reference

Breast cancer after treatment of Hodgkin's disease.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

Late effects of treatment for childhood Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

Radiation effects on breast cancer risk: a pooled analysis of eight cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

Validation studies for models projecting the risk of invasive and total breast cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

Breast cancer risk prediction with a log-incidence model: evaluation of accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

Breast cancer and other second neoplasms after childhood Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

Breast cancer risks for BRCA1/2 carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI290

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJI290

1 reference

3 September 2017

1 reference